Inogen (INGN) Cash from Investing Activities (2013 - 2026)
Inogen (INGN) reported Cash from Investing Activities of -$2.0 million for Q1 2026, up 3.09% year-over-year from -$1.9 million in Q1 2025, and down 30.28% quarter-over-quarter from -$1.5 million in Q4 2025.
Inogen (INGN) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Cash from Investing Activities data on file, last reported at -$2.0 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$2.0 million, up 3.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$26.1 million (down 917.75% YoY), and the FY2025 annual result was -$26.2 million, down 87.54% from the prior year.
- Cash from Investing Activities fell to -$2.0 million in Q1 2026 per INGN's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $11.5 million in Q4 2024 and troughed at -$45.8 million in Q3 2023.
- A 5-year average of -$6.6 million and a median of -$2.0 million in 2025 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities soared 210.57% in 2022, then tumbled 2191.85% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$6.9 million in 2022, then jumped by 159.45% to $4.1 million in 2023, then jumped by 179.55% to $11.5 million in 2024, then slumped by 113.14% to -$1.5 million in 2025, then plunged by 30.28% to -$2.0 million in 2026.
- Business Quant data shows INGN's Cash from Investing Activities at -$2.0 million in Q1 2026, -$1.5 million in Q4 2025, and -$82000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | -1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.98 Mn |
| Mar 31, 2026 | -1.98 Mn |
| Dec 31, 2025 | -1.52 Mn |
| Dec 31, 2025 | -1.52 Mn |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | -22.57 Mn |
| Jun 30, 2025 | -22.57 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Mar 31, 2025 | -2.04 Mn |
| Dec 31, 2024 | 11.54 Mn |
| Dec 31, 2024 | 11.54 Mn |
| Sep 30, 2024 | 305,000.00 |
| Sep 30, 2024 | 305,000.00 |
| Jun 30, 2024 | -12.38 Mn |
| Jun 30, 2024 | -12.38 Mn |
| Mar 31, 2024 | -13.44 Mn |
| Mar 31, 2024 | -13.44 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Dec 31, 2023 | 4.13 Mn |